These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 20923622

  • 1. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
    Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA.
    J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
    [Abstract] [Full Text] [Related]

  • 2. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
    Goldberg JF, Brooks JO, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.
    J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
    [Abstract] [Full Text] [Related]

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Feb; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 4. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Feb; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 5. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
    Ghaemi SN, Goodwin FK.
    J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
    [Abstract] [Full Text] [Related]

  • 6. [Lithium and anticonvulsants in bipolar depression].
    Samalin L, Nourry A, Llorca PM.
    Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
    [Abstract] [Full Text] [Related]

  • 7. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.
    BMC Psychiatry; 2012 Dec 17; 12():228. PubMed ID: 23244301
    [Abstract] [Full Text] [Related]

  • 8. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA.
    J Clin Psychiatry; 2008 Dec 17; 69 Suppl 5():9-15. PubMed ID: 19265635
    [Abstract] [Full Text] [Related]

  • 9. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder.
    Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA.
    Compr Psychiatry; 2016 Apr 17; 66():146-56. PubMed ID: 26995248
    [Abstract] [Full Text] [Related]

  • 10. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
    Möller HJ, Grunze H, Broich K.
    Eur Arch Psychiatry Clin Neurosci; 2006 Feb 17; 256(1):1-16. PubMed ID: 16078087
    [Abstract] [Full Text] [Related]

  • 11. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L, Llorca PM.
    Encephale; 2012 Apr 17; 38(2):126-32. PubMed ID: 22516270
    [Abstract] [Full Text] [Related]

  • 12. An analysis of the efficacy of treatments for bipolar depression.
    Nierenberg AA.
    J Clin Psychiatry; 2008 Apr 17; 69 Suppl 5():4-8. PubMed ID: 19265634
    [Abstract] [Full Text] [Related]

  • 13. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH, Choi SW, Joe SH, Ha TH, Yoo HJ, Choi JE, Cha B, Ha K.
    Nord J Psychiatry; 2008 Apr 17; 62(6):496-502. PubMed ID: 18841509
    [Abstract] [Full Text] [Related]

  • 14. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
    Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R.
    J Am Acad Child Adolesc Psychiatry; 2012 Sep 17; 51(9):867-78. PubMed ID: 22917200
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JC, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.
    Arch Gen Psychiatry; 2000 May 17; 57(5):481-9. PubMed ID: 10807488
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of bipolar disorders].
    Schmauss M, Messer T.
    MMW Fortschr Med; 2009 Mar 26; 151(13):74-8. PubMed ID: 19504825
    [No Abstract] [Full Text] [Related]

  • 17. [Puzzling bipolar disorder].
    Forsthoff A, Born C, Grunze H.
    MMW Fortschr Med; 2005 May 17; 147 Spec No 2():32-6. PubMed ID: 15968870
    [Abstract] [Full Text] [Related]

  • 18. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov 17; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
    Walkup JT, Wagner KD, Miller L, Yenokyan G, Luby JL, Joshi PT, Axelson DA, Robb A, Salpekar JA, Wolf D, Sanyal A, Birmaher B, Vitiello B, Riddle MA.
    J Am Acad Child Adolesc Psychiatry; 2015 Dec 17; 54(12):1008-19. PubMed ID: 26598476
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board.
    J Affect Disord; 2008 Feb 17; 106(1-2):63-72. PubMed ID: 17582508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.